Advancing Vaccines
For Better Lives

Welcome to Valneva

We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We have leveraged our expertise and capabilities both to commercialize three vaccines, including the world’s first and only chikungunya vaccine, and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease and Zika.

Learn More

Check out our 2023 Annual Business Report

Learn More

Follow Us

🏆 We’re honored to have won Breakthrough of the Year for our chikungunya vaccine at the 2024 European Mediscience Awards! @EuromedEvent

Today is #WorldEnvironmentDay 🌍

Join us in advocating for positive change to protect our planet. 💚

Learn more about our sustainability efforts in our recent blog: https://rb.gy/phghxc

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
https://valneva.com/press-release/valneva-announces-availability-of-documentation-for-its-shareholder-meeting-and-provides-corporate-update

Load More